News from Shanghai, China

Follow

News from Shanghai, China

Stay current with all the latest and breaking news about Shanghai, China, compare headlines and perspectives between news sources on stories happening today. In total, 1,284 stories have been published about Shanghai, China which Ground News has aggregated in the past 3 months.

Follow

Stay current with all the latest and breaking news about Shanghai, China, compare headlines and perspectives between news sources on stories happening today. In total, 1,284 stories have been published about Shanghai, China which Ground News has aggregated in the past 3 months.

Weather

14°C

Saturday12° | 25°C

Sunday10° | 24°C

Monday12° | 26°C

Tuesday14° | 28°C

Wednesday14° | 30°C

Thursday16° | 26°C

Local News Publishers

Untracked bias

Suggest a source

Looking for a source we don't already have? Suggest one here.

---

Top Shanghai, China News

Innovation · Shanghai

Smartee Pioneers a New Phase in Orthodontics with Silicon Valley Founder Mode

66% Center coverage: 41 sources

SHANGHAI, March 30, 2025 /PRNewswire/ -- As the clear aligner business enters the second quarter of 2025, it shows a promising growth trend. With increasing competition and innovation in the market, Smartee Denti-Technology remains committed to its "Founder Mode," aiming…See the Story

Shanghai, China · Shanghai

Blokees Officially Announces the Launch of the second season of 3rd BFC Creation Competition: Breaking the Cocoon Season

72% Center coverage: 18 sources

SHANGHAI, April 1, 2025 /PRNewswire/ -- On April 1st, the second season of the third BFC (Blokees Figures Creator) Creation Competition, themed "Breaking the Cocoon Season," was officially launched. This year's competition continues to adopt a dual-track model comprising the…See the Story

Merck · Shanghai

Merck Exercised the Option for the Global Rights of Abbisko Therapeutics's Pimicotinib

53% Center coverage: 15 sources

SHANGHAI, March 31, 2025 /PRNewswire/ -- On April 1, 2025, Beijing Time, Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics") announced that Merck has exercised the global commercialization option for pimicotinib (ABSK021), with an option exercise fee of USD85.0 million, under the…See the Story

---

Local News Publishers

Untracked bias

---

Breaking News Topics Related to Shanghai, China

Israel-Hamas Conflict